Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours
Authors:
Open Access
- 8 April 2022
- journal article
- review article
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 8 (1) , 1-31
Abstract
Background: In recent years, the field of nanotechnology and nanomedicine has transformed the pharmaceutical industry with the development of novel drug delivery systems that overcome the shortcomings of traditional drug delivery systems. Nanostructured lipid carriers (NLCs), also known as the second-generation lipid nanocarriers, are one such efficient and targeted drug delivery system that has gained immense attention all across due to their myriad advantages and applications. Scientific advancements have revolutionized our health system, but still, brain diseases like brain tumour have remained formidable owing to poor prognosis and the challenging drug delivery to the brain tissue. In this review, we highlighted the application and potential of NLCs in brain-specific delivery of chemotherapeutic agents.Main body: NLCs are lipid-based formulations with a solid matrix at room temperature and offer advantages like enhanced stability, low toxicity, increased shelf life, improved drug loading capacity, and biocompatibility over other conventional lipid-based nanocarriers such as nanoemulsions and solid lipid nanoparticles. This review meticulously articulates the structure, classification, components, and various methods of preparation exemplified with various research studies along with their advantages and disadvantages. The concept of drug loading and release has been discussed followed by a brief about stability and strategies to improve stability of NLCs. The review also summarizes variousin vitroand in vivo research studies on NLCs encapsulated with cytotoxic drugs and their potential application in brain-specific drug delivery.Conclusion: NLCs are employed as an important carrier for the delivery of food, cosmetics, and medicines and recently have been used in brain targeting, cancer, and gene therapy. However, in this review, the applications and importance of NLCs in targeting brain tumour have been discussed in detail stating examples of various research studies conducted in recent years. In addition, to shed light on the promising role of NLCs, the current clinical status of NLCs has also been summarized.GraphicalKeywords
This publication has 242 references indexed in Scilit:
- Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopeciaSaudi Pharmaceutical Journal, 2013
- A Review of Hot-Melt Extrusion: Process Technology to Pharmaceutical ProductsISRN Pharmaceutics, 2012
- Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusionInternational Journal of Nanomedicine, 2012
- Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapyLipids in Health and Disease, 2012
- Novel bio-active lipid nanocarriers for the stabilization and sustained release of sitosterolNanotechnology, 2012
- In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administrationInternational Journal of Nanomedicine, 2012
- Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug DeliveryJournal of Drug Delivery, 2011
- Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug DeliveryAAPS PharmSciTech, 2010
- Nanoparticle-based targeted drug deliveryExperimental and Molecular Pathology, 2009
- Production of drug-loaded lipid nanoparticles based on phase behaviors of special hot microemulsionsColloids and Surfaces A: Physicochemical and Engineering Aspects, 2008